Pelago operates a digital clinic that provides prevention-to-recovery substance use management for employers and health plans, combining cognitive behavioral therapy (CBT) and medication‑assisted treatment (MAT). The company runs a 100% fees‑at‑risk model and reports demonstrated ROI from clinical claims analysis (a 3.0x ROI and $9,367 annual medical‑claims reduction per participant versus a control group). Tens of thousands of members enroll in Pelago’s program each year, and more than 3.4 million people now have access to the digital clinic. Pelago says customers have driven tenfold growth in revenue and eligible lives since its Series B two years ago. The new capital will be used to accelerate the product roadmap, extend the continuum of care, and advance clinical research. Pelago emphasizes integration with health plans, pharmacy benefit managers and wellness platforms to expand access and measurable cost savings.

Total raised

$58M

Funding rounds

1

Latest round

Series C

Latest activity

Mar 2024